Gangavarapu Lakshmi Suryateja, Chanbour Hani, Bendfeldt Gabriel A, Younus Iyan, Jonzzon Soren, Chotai Silky, Abtahi Amir M, Stephens Byron F, Zuckerman Scott L
Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Neurosurg Pract. 2024 Jun 20;5(3):e00096. doi: 10.1227/neuprac.0000000000000096. eCollection 2024 Sep.
Whether unintended durotomy in metastatic spine surgery seeds tumor in the central nervous system (CNS) remains unknown. Our objectives were to (1) determine the rate of unintended durotomy, (2) identify the preoperative and perioperative factors that increase the risk of unintended durotomy, and (3) determine whether unintended durotomy affected local recurrence (LR), any spinal recurrence, and overall survival.
A single-center, retrospective cohort study of patients undergoing metastatic spine surgery between January 2010 to January 2021 was undertaken. The primary exposure variable was the occurrence of unintended durotomy. Multivariable logistic/linear regression were performed controlling for age, body mass index, tumor size, other organ metastases, and preoperative radiotherapy/chemotherapy.
Of 354 patients undergoing surgery for extradural spinal metastasis, 19 patients (5.4%) had an unintended durotomy. Preoperatively: No difference was found between patients with and without unintended durotomy regarding basic demographics, comorbidities ( = .645), or tumor histology ( = .642). Preoperative chemotherapy/radiotherapy were similar between the 2 groups. Perioperatively: Although patients with unintended durotomy had more costotransversectomies (36.8% vs 12.8%, = .010), no difference was found in tumor characteristics, operative time (337.4 vs 310.6 minutes, = .150), blood loss (1012.8 vs 883.8 mL, = .157), length of stay (6.4 vs 6.9 days, = .452), or overall reoperation/readmission. Long-term: No difference was seen in CNS spread between those with unintended durotomy and no durotomy (10.5% vs 3.0%, = .077). LR (5.3% vs 12.2%, = .712), time to LR (388.0 vs 213.3 ± 359.8 days, log-rank; = .709), any spinal recurrence (26.3% vs 34.0%, = .489), overall survival (21.05% vs 34.3%, = .233), and time to death (466.9 ± 634.7 vs 465.8 ± 665.4 days, log-rank; = .394) were similar on multivariable Cox regressions.
In patients undergoing surgery for extradural spinal metastases, 5% had an unintended durotomy, and costotransversectomies were associated with increased risk of an unintended durotomy. Unintended durotomies did not lead to increased LR or shorter survival. Taken together, shortened survival due to seeding tumor into the CNS after an unintended durotomy was not observed.
转移性脊柱手术中意外硬脊膜切开是否会导致肿瘤在中枢神经系统(CNS)播散尚不清楚。我们的目的是:(1)确定意外硬脊膜切开的发生率;(2)识别增加意外硬脊膜切开风险的术前和围手术期因素;(3)确定意外硬脊膜切开是否会影响局部复发(LR)、任何脊柱复发及总生存期。
对2010年1月至2021年1月期间接受转移性脊柱手术的患者进行单中心回顾性队列研究。主要暴露变量为意外硬脊膜切开的发生情况。进行多变量逻辑/线性回归分析,对年龄、体重指数、肿瘤大小、其他器官转移情况以及术前放疗/化疗进行控制。
在354例行硬膜外脊柱转移瘤手术的患者中,19例(5.4%)发生了意外硬脊膜切开。术前:意外硬脊膜切开患者与未发生意外硬脊膜切开患者在基本人口统计学特征、合并症(P = 0.645)或肿瘤组织学(P = 0.642)方面未发现差异。两组术前化疗/放疗情况相似。围手术期:尽管意外硬脊膜切开患者行肋横突切除术的比例更高(36.8%对12.8%,P = 0.010),但在肿瘤特征、手术时间(337.4对310.6分钟,P = 0.150)、失血量(1012.8对883.8 mL,P = 0.157)、住院时间(6.4对6.9天,P = 0.452)或总体再次手术/再次入院方面未发现差异。长期来看:意外硬脊膜切开患者与未发生硬脊膜切开患者在CNS播散方面未发现差异(10.5%对3.0%,P = 0.077)。多变量Cox回归分析显示,LR(5.3%对12.2%,P = 0.712)、至LR时间(388.0对213.3±359.8天,对数秩检验;P = 0.709)、任何脊柱复发(26.3%对34.0%,P = 0.489)、总生存期(21.05%对34.3%,P = 0.233)以及至死亡时间(466.9±634.7对465.8±665.4天,对数秩检验;P = 0.394)相似。
在接受硬膜外脊柱转移瘤手术的患者中,5%发生了意外硬脊膜切开,肋横突切除术与意外硬脊膜切开风险增加相关。意外硬脊膜切开并未导致LR增加或生存期缩短。总体而言,未观察到意外硬脊膜切开后因肿瘤播散至CNS而导致生存期缩短的情况。